RARECAN LIMITED
Company number 12844377 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£676,660
Balance sheet as at 2025-08-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2020-08-28
- Employees
- 7 (2025 accounts · was 9 in 2024)
- Registered office
- 8 Park Avenue, Hexham, Northumberland, United Kingdom, NE46 3EN
- Postcode
- NE46 3EN
- Capital
- 14 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-08-31
- Next due by
- 2027-05-31
- Financial year end
- 31 August
Confirmation statement
- Last statement dated
- 2026-06-03
- Next due by
- 2027-06-17
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 4 current · 2 resigned
Data protection registration
Registered with the ICO as a data protection fee payer — ZA752189 (Tier 1), registered since 2020.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Contact details
- Website
- rarecan.org
Cancer treatment built around you. RareCan helps you and your clinician make more informed decisions about your cancer treatment, by […]
Previous company names
| Name | Date changed |
|---|---|
| MORAMORA LTD | 2020-11-24 |
Among its peers
Top 25%
by shareholders' funds, of 34 similar companies in NE
Trading since 2020.
Competitors Newcastle Upon Tyne
-
5. PXD LIMITED
This company ranks 8 among research and experimental development on biotechnology in Newcastle Upon Tyne.
The class of 2020
41%
of the 595 companies in this sector incorporated in 2020 are still active today; 55% have since been dissolved.
A fact about the year, not a forecast for this company.